Clinical trial
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic…
NCT00009906 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00009906 |
|---|---|
| Title | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor |
| Official title | Phase III Randomized, Intergroup Trial Assessing the Clinical Activity Of STI-571 at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the Kit Receptor Tyrosine Kinase (CD117) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Eastern Cooperative Oncology Group SWOG Cancer Research Network NCIC Clinical Trials Group |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumor |
| Intervention type | Drug |
| Interventions | Imatinib Mesylate |
| Enrollment | 748 |
| Start date | Dec 1, 2000 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2014 |
| First posted | Feb 3, 2004 |
| Last update posted | Dec 23, 2014 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: